Comparative study of pulmonary circulation and myocardial function in patients with β-thalassemia intermedia with and without hydroxyurea, a case-control study

European Journal of Haematology

Volumn 87, Issue 1, 2011, Pages 61-67

  Amoozgar, Hamid ^a   Farhani, Nahal ^a   Khodadadi, Neda ^a   Karimi, Mehran ^b   Cheriki, Sirous ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hydroxyurea; Pulmonary hypertension; Thalassemia intermedia

Indexed keywords

HYDROXYUREA;

ADULT; ARTICLE; BETA THALASSEMIA; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART FUNCTION; HUMAN; IMAGE ANALYSIS; LUNG CIRCULATION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHOOL CHILD; SYSTOLE; TISSUE DOPPLER IMAGING; TRICUSPID VALVE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; ANTIMETABOLITES; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART; HEMOGLOBINS; HUMANS; HYDROXYUREA; HYPERTENSION, PULMONARY; MALE; MYOCARDIAL CONTRACTION; PULMONARY CIRCULATION; TRICUSPID VALVE; YOUNG ADULT;

EID: 79959526197     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01620.x     Document Type: Article

References (34)

1. Higgs DR, Thein SL, Woods WG. The physiology of the thalassemias. In: Weatherall DJ, Clegg B, eds. The Thalassemia Syndrome, 4th edn. Oxford, UK: Blackwell, Oxford Science Ltd, 2001:265-84.
2. EI RF, Cappellini MD, Inati A, Taher A. Beta-thalassemia intermedia: an overview. Pediatr Ann 2008;37:322-8.
3. Rund D, Rachmilewitz EA. Advances in the pathophysiology and treatment of thalassemia. Crit Rev Oncol Hematol 1995;20:237-54.
4. Forget BG. Thalassemia syndromes. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds. Hematology: Basic Principles and Practice. New York: Churchill Livingstone, 2000:485.
5. Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica 1995;80:58-68.
6. Rund D, Rachmilewitz E. New trends in the treatment of b-thalassemia. Crit Rev Oncol Hematol 2000;33:105-18.
7. Olivieri NF. Reactivation of fetal hemoglobin in patients with -Beta-thalassemia. Semin Hematol 1996;33:24-42.
8. Loukopoulos D, Voskaridou E, Stamoulakatou A, et al. Hydroxyurea therapy in thalassemia. Ann NY Acad Sci 1998;850:120-8.
9. Saxon BR, Rees D, Olivieri NF. Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in beta-thalassaemia. Br J Haematol 1998;101:416-9.
10. Karimi M, Borzouee M, Mehrabani A, Cohan N. Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. Eur J Haematol 2009;82:213-8.
11. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a non-invasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33.
12. Iarussi D, Di Salvo G, Pergola V, Coppolino P, Tedesco MA, Ratti G, Esposito L, Calabrò R. Pulsed tissue imaging and myocardial function in thalassemia major. Heart Vessels 2003;18:1-6.
13. Isma'eel H, El Chafic AH, El Rassi F, Inati A, Koussa S, Daher R, Gharzuddin w, Alam S, Taher A. Relation between iron overload indices, cardiac echo-doppler, and biochemical markers in thalassemia intermedia. Am J Cardiol 2003;102:363-7.
14. Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80.
15. Sohn DW, Kim YJ, Kim Hch, Chun HG, Park YB, Choi YS. Evaluation of left ventricular diastolic function when mitral E and A waves are completely fused: role of assessing mitral annulus velocity. J Am Soc Echocardiogr 1999;12:203-8.
16. Meluzín J, Spinarová L, Bakala J, Toman J, Krejcí J, Hude P, Kára T, Soucek M. Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion; a new, rapid, and non-invasive method of evaluating right ventricular systolic function. Eur Heart J 2001;22:340-8.
17. Karimi M, Darzi H, Yavarian M. Hematologic and clinical response of thalassemia intermedia patients to hydroxyurea during 6years therapy in Iran. J Pediatr Hematol Oncol 2005;27:380-5.
18. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-93.
19. Modell B, Khan M, Darlison M. Survival in beta-thalassemia major in UK: data from the UK Thalassemia Register. Lancet 2000;355:2051-2.
20. Li CK, Luk CW, Ling SC, Chik KW, Yuen HL, Li CK, Shing MM, Chang KO, Yuen PM. Morbidity and mortality patterns of thalassaemia major patients in Hong Kong: retrospective study. Hong Kong Med J 2002;8:255-60.
21. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, Karagiorga M. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest 2005;127:1523-30.
22. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci 1998;850:191-201.
23. Aessopos A, Kati M, Farmakis D. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Haematologica 2007;92:658-65.
24. Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, Joussef J, Rombos J, Loukopoulos D. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 2001;97:3411-6.
25. Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP. Hydroxyurea in thalassemia intermedia: A promising therapy. Ann Hematol 2005;84:441-6.
26. Hajjar FM, Pearson HA. Pharmacological treatment of thalassemia intermedia with hydroxyurea. J Pediatr 1994;125:490-2.
27. Styles L, Lewis B, Foote D, Cuca L, Vichinski E. Preliminary report: hydroxyurea produces significant clinical response in thalassemia intermedia. Ann N YAcad Sci. 1998;850:461-2.
28. Hoppe C, Vichinski E, Lewis B, Foote D, Styles L. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol 1999;62:221-7.
29. Cianciulli P, Di Toritto TC, Sorrentino F, Sergiacomi L, Massa A, Amadori S. Hydroxyurea therapy in paraparesis and cauda equina syndromes due to extramedullary haematopoiesis in thalassaemia: improvement of clinical and haematological parameters. Eur J Haematol 2000;64:426-9.
30. El Alfy MS, Tantawy AAG. One year pilot trial of hydroxyurea in transfusion dependent β-thalassemia intermedia. Blood 2000;96:3759.
31. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 2010;115:1886-92.
32. Yamazaki N, Mine Y, Sano A, Hirama M, Miyatake K, Yamagishi M, Tanaka N. Analysis of ventricular wall motion using color-coded tissue Doppler imaging system. Jpn J Appl Physiol 1994;33:3141-6.
33. Sutherland GR, Steward MJ, Grounstroem KWE, Moran CM, Fleming AD, Guell-Peris PJ, Riemesma RA, Fenn LN, Fox KAA, McDicken WN. Colour Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 1994;7:441-58.
34. Fleming AD, Xia X, McDicken WN, Sutherland GR, Fenn L. Myocardial velocity gradient by Doppler imaging. Br J Radiol 1994;67:679-88.